ArticleBioprocess and biosystems engineering2026
Raman-guided sample subset selection for cost-efficient offline calibration in bioprocesses.
Article in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In bioprocess engineering, model-based methods play a vital role in understanding complex dynamics of novel species or strains. However, the model development is often hampered by prohibitive costs associated with redundant reference analyses and poorly informed sampling schedules due to insufficient prior knowledge about the process dynamics. We propose a model-free PAT strategy, termed Raman-guided sample subset selection (RGSS) to prioritise informative offline reference assays from inline Raman spectra before nonlinear model calibration. RGSS is demonstrated with Saccharomyces cerevisiae fed-batch fermentations and evaluated by auto- and cross-validation (CV), as well as with practical identifiability analysis of an unstructured mechanistic model. The approach is implemented using constrained vector quantization (CVQ) with full-spectrum and analyte-specific wavenumber-selection and benchmarked against uniform-in-time sampling, random subsampling, and Kennard-Stone (KS) selection. The best RGSS scenarios, using only five selected reference assays per analyte, retained offline CV accuracy (NRMSE = 3.49) close to the full-data reference (NRMSE = 3.29) using all 22 samples. KS selection was also competitive for ten selected samples (NRMSE = 3.79), whereas uniform-in-time sampling resulted in higher CV errors for five and ten samples (8.47 and 65.57). Random subsampling occasionally produced competitive subsets, but showed broad variability over 20 random runs (NRMSE median [IQR]: 6.14 [4.84-47.76] and 15.48 [5.07-44.34]) for five and ten randomly selected samples. These results support RGSS as a cost-efficient, spectrally informed sample subset selection framework for prioritising offline assays in model-based bioprocess development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.